ICG
EW icon

InterOcean Capital Group’s Edwards Lifesciences EW Stock Holding History

InterOcean Capital Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,089
Closed -$236K – 498
2023
Q4 		$236K Sell
3,089
-360
-10% -$25K 0.01% 415
2023
Q3 		$239K Sell
3,449
-1,987
-37% -$160K 0.01% 386
2023
Q2 		$513K Sell
5,436
-2,163
-28% -$188K 0.02% 267
2023
Q1 		$629K Sell
7,599
-303
-4% -$23.8K 0.02% 225
2022
Q4 		$590K Sell
7,902
-56
-0.7% -$4.32K 0.02% 233
2022
Q3 		$658K Buy
7,958
+1,856
+30% +$179K 0.03% 202
2022
Q2 		$580K Buy
+6,102
New +$632K 0.02% 217
2022
Q1 		– Sell
-1,567
Closed -$203K – 294
2021
Q4 		$203K Buy
+1,567
New +$183K 0.01% 249

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

InterOcean Capital Group's EW Position: Q1 2024 in Review

InterOcean Capital Group sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 3,089 shares — an estimated $236K sold.

InterOcean Capital Group first reported a position in EW in Q4 2021 and held it in 8 quarters. The position peaked at $658K in Q3 2022. 1,279 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • InterOcean Capital Group reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • InterOcean Capital Group sold 3,089 Edwards Lifesciences shares in Q1 2024, an estimated $236K.
  • InterOcean Capital Group first reported a position in Edwards Lifesciences in Q4 2021 and held it in 8 quarters.
  • InterOcean Capital Group's Edwards Lifesciences position peaked at $658K in Q3 2022.
  • 1,279 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.